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OBJECTIVES Our goal was to identify early changes in myocardial physical properties in children with
Duchenne muscular dystrophy (DMDch).
BACKGROUND Duchenne muscular dystrophy (DMD) is caused by the absence of dystrophin, which triggers
complex molecular and biological events in skeletal and cardiac muscle tissues. Although
about 30% of patients display overt signs of cardiomyopathy in the late stage of the disease,
it is unknown whether changes in myocardial physical properties can be detected in the early
(preclinical) stages of the disease.
METHODS We performed an ultrasonic tissue characterization (UTC) analysis of myocardium in
DMDch with normal systolic myocardial function and no signs of cardiomyopathy. Both the
cyclic variation of integrated backscatter (cvIBS) and the calibrated integrated backscatter
(cIBS) were assessed in 8 myocardial regions of 20 DMDch, age 7  2 years (range 4 to 10
years), and in 20 age-matched healthy controls.
RESULTS We found large differences in the UTC data between DMDch and controls; the mean value
of cvIBS was 4.4  1.5 dB versus 8.8  0.8 dB, whereas the mean value of cIBS was 36.4
 7.1 dB versus 26.9  2.0 dB (p  106 for both). In DMDch, all eight sampled segments
showed cIBS mean values to be significantly higher and cvIBS mean values to be significantly
lower than those in the controls. Finally, interindividual differences were greater in DMDch
than in controls for both parameters.
CONCLUSIONS The myocardium in DMDch displays UTC features different from those in healthy controls.
These results show that lack of dystrophin is commonly associated with changes in myocardial
features well before the onset of changes of systolic function and overt
cardiomyopathy. (J Am Coll Cardiol 2003;42:309–16) © 2003 by the American College of
Cardiology Foundation
Duchenne muscular dystrophy (DMD) is an X-linked
recessive disorder that affects approximately 1 of 3,500 male
births and is caused by the absence of dystrophin, a 427-kd
protein located on the inner sides of the skeletal and cardiac
muscle cells. Dystrophin links the muscle cytoskeleton to
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the extracellular matrix by interacting with a large number
of membrane proteins (1), and it might also play a role in
the regulation or localization of signal transduction mole-
cules (2). Absence of dystrophin generates progressive
damage of skeletal muscle, causing a decrease in function
that is clinically evident in childhood, although subtle
histological changes may occur earlier (3,4).
Absence of dystrophin triggers a dystrophic process
also in the myocardium, accounting for the severe fibrosis
found at endomyocardial biopsy (5) and postmortem (6)
examination. Although characteristic electrocardiographic
changes become evident in 80% to 90% of DMD
children (DMDch) over 10 years of age (7), cardiomyo-
pathic symptoms emerge in only about 30% of cases (8).
However, it is not clear whether early changes in myocardial
physical properties may be present even in asymptomatic
DMDch who have normal electrocardiogram (ECG) and
left ventricular systolic function. No previous study has
shown any changes in myocardial features in these patients.
Ultrasonic tissue characterization (UTC) can be used to
obtain a noninvasive characterization of the physical prop-
erties of the myocardium. Mori et al. (9) recently described
UTC abnormalities in a group of 25 relatively old DMD
patients (17.6  2.7 years), most of whom showed overt
cardiomyopathy. In the present study, we used UTC to
detect early changes in myocardial physical properties in
asymptomatic DMDch with no other signs of cardiac
involvement and with normal ECG and left ventricular
systolic function.
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METHODS
Patients. We enrolled 20 DMDch age 4 to 10 years (mean
age 7  2 years) followed at the Center for Neuromuscular
Disease (Uildm of Rome, Italy) and 20 healthy, age-matched
controls (mean age 8 1 years, pNS). None of the patients
was under pharmacologic treatment. The study was approved
by the Ethical Committee of Catholic University of Rome.
Written informed consent was obtained in all cases.
In all patients, diagnosis of DMD was confirmed by
muscle biopsy that showed the absence of dystrophin. In
addition, an out-of-frame dystrophin gene deletion was
found in 13 cases (Table 1). All DMDch had normal
cardiologic examination, ECG, systolic function, and seg-
mental wall motion at baseline echocardiography (Table 1).
Ejection fraction (EF), calculated by Simpson’s rule and
Bullet methods, and rate-corrected velocity of circumferen-
tial fiber shortening (Vcfc) (10) were within normal limits in
all patients. A detailed clinical and neurological examination
was performed in all patients, including a standardized
Gowers maneuver. For the purpose of this study, a signif-
icant muscle weakness was defined as the inability to stand
up autonomously during the Gowers maneuver.
Integrated backscatter (IBS) data acquisition and analysis.
We used a commercially available echocardiograph (Sonos
5500, Agilent, Andover, Massachusetts) equipped with a 2
to 4 MHz phased-array probe. Ultrasonic tissue character-
ization was performed by an Agilent Acoustic Densitometry
software. The IBS data were displayed using a logarithmic
scale in dB, with a dynamic processor range of 64 dB.
A preprocessing value of 1, a postprocessing gray-scale
curve setting of A (the most linear setting), a transmit power
of 35 dB, a mechanical index of 0.5, and a time-gain
compensation of 140 dB were kept constant in all patients,
all controls, and all horizontal image sections. This was easy
to do because the population studied (children) was homo-
geneous for body habit. All images were obtained in the
fundamental imaging mode. Acoustic densitometry image
loops were acquired in digital format: 60 frames from
consecutive cardiac cycles (2.48 s at 30 frames/s) were
displayed after scan conversion and stored on optical disk for
off-line analysis.
From the acoustic densitometry curve we measured two
parameters: 1) the magnitude of cyclic variation of the IBS
(cvIBS), which is the difference between the average peak
(end-diastole) and average nadir (end-systole) values of IBS;
and 2) the calibrated IBS (cIBS), which was derived from
the absolute IBS value (Fig. 1). For IBS calibration we
measured blood IBS with a circular-shaped region of
interest (ROI) (41  41 pixels) in the left ventricular cavity
at the mid-level (11).
All analyses were performed in the parasternal short-axis
view (12). The UTC parameters such as cvIBS and cIBS
have been shown (13,14) to depend significantly on the
Abbreviations and Acronyms
cIBS  calibrated integrated backscatter
cvIBS  cyclic variation of integrated backscatter
DMD  Duchenne muscular dystrophy
DMDch  Duchenne muscular dystrophy children
ECG  electrocardiogram
EF  ejection fraction
IBS  integrated backscatter
ROI  region of interest
UTC  ultrasonic tissue characterization
Vcfc  rate-corrected velocity of circumferential fiber
shortening
Table 1. Clinical and Echocardiographic Data in Children With Duchenne Muscular Dystrophy
Patient Age (yrs)
Dystrophin





1 7.05 Absent Exons 5-7 61.2 1.33 No
2 4.05 Absent Exons 53-54 63.5 1.44 No
3 4.09 Absent Exon 52 67.1 1.32 No
4 7.06 Absent Exon 45 60.3 1.11 No
5 4.08 Absent ND 63.9 0.949 No
6 4.06 Absent Exons 49-52 59.5 0.985 No
7 8 Absent Exon 45 59.6 0.853 Yes
8 4.03 Absent Exon 52 63.1 1.22 No
9 9 Absent Exons 45-50 56.4 0.702 Yes
10 6.02 Absent Exons 48-52 66.9 1.07 No
11 6.02 Absent ND 61.7 1.07 No
12 7 Absent ND 60.7 0.979 No
13 10 Absent ND 63 1.28 Yes
14 8.03 Absent Exon 8 57.7 0.949 No
15 8.07 Absent ND 55.9 1.1 Yes
16 10.02 Absent ND 55.3 0.931 No
17 6.07 Absent ND 56.5 0.906 No
18 8.08 Absent Exons 50-54 59.9 0.977 No
19 4.08 Absent Exons 45-52 62.8 1.66 No
20 8.04 Absent Exons 5-7 58.1 1.18 Yes
EF  ejection fraction; ND  not deleted; Vcfc  rate-corrected velocity of circumferential fiber shortening.
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angle between the ultrasonic beam and the myofiber direc-
tion, an effect known as anisotropy. To minimize the impact
of myocardial anisotropy, we chose to analyze data from
segments of the parasternal short-axis view in which the
beam is approximately perpendicular to the local myofiber
direction (Fig. 2). Locations at 5, 6, and 7 o’clock (corre-
sponding to plb, ib, ilm, im, and ia; Fig. 2), satisfy this
condition. Locations near 4 o’clock (alb, alm, and la; see Fig.
2) are somewhat less perpendicular.
The UTC parameters were measured at the basal, mid
(papillary muscles), and apical levels during end-expiration.
Circular, elliptical, and rectangular-shaped ROI (21  21
pixels) were placed in the midmyocardial layer of eight
different myocardial segments (15) (Fig. 2). For both cvIBS
and cIBS, the mean value obtained from the three ROIs was
used for statistical analysis. To minimize high-frequency
scatter noise we set the smoothing filters to a high level;
lateral-gain compensation was not used in this study.
Figure 1. Plot of the cyclic variation of integrated backscatter (cvIBS) sampled on the inferior base segment and the calibrated integrated backscatter (cIBS)
in a four-year-old Duchenne muscular dystrophy (DMD) child (upper curve) and in an age-matched control (lower curve). The cvIBS and cIBS values
are respectively smaller and higher in the DMD child than in the control.
Figure 2. A 16-segment model was used for ultrasound tissue characterization analysis. The myocardial segments sampled were as follows: alb 
anterolateral base; alm  anterolateral mid; ia  inferior apex; ib  inferior base; ilm  inferolateral mid; im  inferior mid; la  lateral apex; plb 
posterolateral base.
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The time-delay value was calculated for each myocardial
segment, in both patients and controls, as described else-
where (16,17). Off-line analysis of cvIBS and cIBS data was
performed by two blinded independent operators.
Interobserver reliability was tested on a sample of 40
myocardial segments. To test intraobserver reliability, the
same 40 segments were re-evaluated after a 20-day period
by one of the two observers. A good reproducibility of
sampled data (3% changes for each value) was obtained in
both cases.
Statistical analysis. Intra- and interobserver variability of
cvIBS and cIBS measurements were estimated by mean
absolute differences between observations. Continuous vari-
ables between groups (patients and controls) were compared
by t test for normally distributed values, as assessed by the
Kolmogorov-Smirnov test (age, EF, etc.). All UTC param-
eters were compared using non-parametric statistics and the
Mann-Whitney U test. The Bonferroni correction was
applied when making multiple comparisons of the same
variable (i.e., the comparison of UTC parameters in multi-
ple myocardial segments, as shown in Table 2). Correlations
were assessed by Spearman’s rank correlation test. A value of
p 0.05 was considered significant. All values are shown as
mean  SD.
RESULTS
Echocardiographic data. No significant differences were
found in the mean values of EF and Vcfc between the
DMDch and healthy controls (p  NS). The individual
data from all patients are reported in Table 1.
UTC analysis. Analysis of both cvIBS and cIBS was
performed on 160 segments in the controls (we studied 8
myocardial segments in each of 20 individuals). Only 145
segments were sampled in the DMDch, as the quality of
imaging was inadequate for UTC analysis from both of the
apical segments of the myocardium in six patients and from
the 3 mid-segments in one patient. The DMDch and
controls displayed different curves of data distribution for
both cvIBS and cIBS (Fig. 3) (p  0.0001 for both).
The mean value of cvIBS was 4.4  1.5 dB (median 4.1
dB, range 2.0 to 9.6 dB) in DMDch and 8.8  0.8 dB
(median 8.8 dB, range 7.0 to 11.4 dB) in controls (p 
0.0001). The mean value of cIBS was 36.4  7.1 dB
(median 36.9 dB, range 21.7 to 57.9 dB) in DMDch, and
26.9  2.0 dB (median 26.7 dB, range 22.2 to 31.6 dB) in
controls (p  0.0001).
In DMDch, the UTC changes occurred in all myocardial
segments: each of the eight sampled segments displayed
cIBS mean values significantly higher and cvIBS mean
Table 2. cIBS, cvIBS, and Time-Delay Mean Values in Children With Duchenne Muscular Dystrophy and Controls
Myocardial Segments (As Shown in Fig. 2)
ib plb alb im ilm alm ia la
cIBS
DMDch
Mean 37.0 41.0 33.6 35.7 41.3 31.9 37.3 32.7
SD 6.5 6.1 5.2 6.4 8.2 6.1 6.8 5.5
Range 21.7–41.7 27.7–51.1 24.2–40.1 23.4–46.1 26.7–57.9 22.2–42.4 24.9–45.0 24.0–40.6
p 106 106 0.0001 0.0003 106 0.003 0.0001 0.0003
Controls
Mean 26.6 28.1 27.4 28.5 26.6 26.9 25.8 25.5
SD 1.5 2.3 1.5 1.8 2.1 1.6 1.7 1.6
Range 23.8–29.3 24.7–31.6 24.5–29.5 24.2–30.8 22.2–30.6 22.9–30.0 23.2–30.4 23.2–29.5
cvIBS
DMDch
Mean 4.1 4.2 4.4 4.7 4.5 4.0 5.6 4.0
SD 1.2 1.5 1.5 1.6 1.0 1.8 1.8 1.6
Range 2.4–6.6 2.1–8.3 2.2–9.2 2.5–9.6 2.5–6.7 2.0–9.2 3.4–9.5 2.0–7.2
p 106 106 106 106 106 106 104 106
Controls
Mean 8.6 8.7 8.4 9.4 8.8 9.0 8.7 8.7
SD 0.6 0.8 0.5 0.8 0.9 0.7 0.9 0.6
Range 7.7–10.0 7.3–10.5 7.6–9.4 7.8–10.8 7.4–11.4 7.0–10.0 7.3–10.1 7.6–9.5
Time delay
DMDch
Mean 1.5 1.2 2.6 1.6 1.2 2.5 1.6 2.6
SD 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2
p NS NS NS NS NS NS NS NS
Controls
Mean 1.6 1.1 2.6 1.6 1.2 2.5 1.6 2.5
SD 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2
Abbreviations as in Figure 1.
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values significantly lower than those of the same segments in
age-matched healthy controls (see Table 2; all p values were
calculated with Bonferroni correction, with n  8 hypoth-
esis tests). The standard deviation in both cvIBS and cIBS
was also significantly higher in patients than in controls,
indicating great variability in these parameters.
The mean value of the normalized time delay was similar
in DMDch and controls in all myocardial segments
Figure 3. (A) Cyclic variation of integrated backscatter (cvIBS): data distribution in Duchenne muscular dystrophy children (DMDch) and controls. (B)
Calibrated integrated backscatter (cIBS): data distribution in DMDch and controls.
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(Table 2). Time delays for those segments for which the
ultrasonic beam is somewhat less perpendicular (segments
alb, alm, and la) were longer than the time delays for
segments near the 6 o’clock position (ib, plb, im, and ia; Fig.
2). Similarly, values of cIBS tended to be higher in the latter
segments (Table 2). The cIBS values were only weakly
correlated with cvIBS values, confirming that the two
parameters reflect different acoustic properties of the myo-
cardium.
Single DMD patient study. In controls, the mean value of
cvIBS ranged between 8.1 and 9.6 dB, whereas 18 DMDch
(90%) showed mean cvIBS values ranging between 3.4 and
5.3 dB; that is, 50% of the values of the control group.
Only the remaining two patients showed different values:
Patient #7 showed intermediate values that were between
DMDch and controls (6.3 dB), and Patient #20 showed
values near normal limits (with a mean 8.0 dB).
The mean values of cIBS in all sampled segments ranged
between 25.4 and 27.9 dB in controls. In DMDch, cIBS
mean values displayed a larger interval, ranging between
25.2 and 45.6 dB. It is worth noting that in only two
patients the cIBS mean value fell within normal limits, and
only one patient (Patient #20) had normal average values of
both cIBS and cvIBS (but with a low value of cvIBS in three
myocardial segments).
In patients there was no correlation between age and
cIBS (r  0.22; p  0.34). However, there was a trend
toward a positive correlation between age and cvIBS (r 
0.40; p  0.08). These data indicate that the myocardial
differences in UTC parameters between DMDch and con-
trols do not increase with age but, for the cvIBS, they appear
to be even more evident in younger children. There was no
relationship between UTC parameters and muscle weakness
assessed as ability to stand up autonomously.
DISCUSSION
Myocardial UTC properties. Our results showed that
UTC properties of the myocardium were clearly different in
DMDch and in controls: in all sampled myocardial seg-
ments, cvIBS mean values were significantly lower and cIBS
mean values significantly higher in DMDch than in age-
matched healthy controls. In addition, for both parameters,
DMDch displayed significant interindividual differences
that were larger than those observed in controls. These
findings show that early changes in myocardial features are
common in young children with DMD, independent of the
presence of ECG or two-dimensional echocardiographic
anomalies.
The mechanisms underlying early UTC changes in
DMDch are not completely clear. Both an increase in cIBS
and a decrease in cvIBS have been correlated with collagen
content and the development of fibrosis in human hearts
and in experimental animals (18–24). It is possible that the
UTC changes observed in DMDch may be secondary to
significant myocardial fibrosis (which has been described in
DMD patients with overt cardiomyopathy). Variations in
the amplitude of cvIBS may also be caused by subtle
changes in myocardial histological properties, reflecting
water content, myofiber orientation, and size (25–28).
Significant myocardial fibrosis is unlikely to be present in
young DMDch with normal ECG and two-dimensional
echocardiogram. This is supported by the lack of correlation
between UTC changes and age (myocardial fibrosis is more
likely to be present in older DMDch) and by the lack of
perfusion/metabolism defects, as detected by positron emis-
sion tomography in DMDch younger than 11 years (29). In
skeletal muscle, extensive fibrosis is prevalent in the latest
stages of DMD, but more subtle changes can be present
earlier and histological abnormalities are evident even dur-
ing fetal life (3,4). Finally, the persistence of proteins
expressed during fetal life has been suggested in DMDch by
expression-profiling studies and confirmed by immunocyto-
chemistry (30). Therefore, numerous histologic and struc-
tural modifications can be detected in the skeletal muscle of
DMDch before muscle weakness and extensive fibrous
tissue replacement begin; it is likely that similar modifica-
tions occur also in the myocardium.
In agreement with this hypothesis, cvIBS values similar
to those we found in DMDch, i.e., a reduction of cvIBS
values, have been described in normal myocardium during
fetal life (31) and in the newborn. After birth, the level of
cvIBS increases to that of infants and children in a few days
or weeks (31). It is possible that the cardiomyocytes of
DMDch retain features typical of fetal myocardial cells (in
particular, the persistence of fetal proteins [30] or an
increased water content). However, a specific assessment of
the mechanisms of early UTC changes in DMDch would
require a myocardial biopsy, which would seem unethical in
this group of asymptomatic subjects.
The angle between the ultrasonic beam and the myofiber
orientation may have important effects on UTC data
(13,14). Indeed, in the present study, the values of time
delays tended to be lower and cIBS higher in segments in
which the beam was more perpendicular to the myofiber
direction. However, this phenomenon cannot influence the
results of our study because wide differences between pa-
tients and controls were observed in all myocardial segments
studied.
Under some circumstances, the signals measured in the
blood pool are dominated by clutter rather than by scatter-
ing from blood cells. Although we cannot rule out the
possibility that the contributions of such clutter signals may
degrade the accuracy of this approach obtaining an absolute
calibration, the differences in cIBS data between DMDch
patients and control subjects (Table 2) are so large that
errors due to clutter appear not to be a factor in this study.
Interindividual differences. We are not surprised at the
wide interindividual differences we found in the myocar-
dium of DMDch (as opposed to the narrow range of UTC
parameters in the controls) because the absence of dystro-
phin may cause tissue changes that can be represented in
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different proportions in each patient and in different myo-
cardial regions. However, despite this large interindividual
variability, almost all DMDch showed large, significant
UTC changes as compared with controls. These results
strongly suggest that UTC changes are associated with an
intrinsic, genetic change in myocardial features. No
DMDch had normal UTC parameters values in all myo-
cardial segments; only one DMDch (Patient #20, age 8.4
years) showed all cIBS values and 5 of 8 cvIBS values that
were in the range of those in the control group. It is
interesting to note that this child had clinical, biochemical,
and molecular characteristics that did not differ from all
other DMDch (in particular, there was evidence of dystro-
phin gene deletion and of significant muscle weakness).
Patient #1, who carried the same deletion-encompassing
exons 5 to 7 of the dystrophin gene, showed the highest
cIBS mean value (i.e., the largest difference from controls in
UTC) in the eight myocardial segments (average 45.6 dB)
but had only minor muscle weakness.
Further studies in a wide group of patients and with a
long-term follow-up would be required to assess whether
the interindividual variation that we found in UTC may
predict the onset of overt cardiomyopathy.
CONCLUSIONS
Our results clearly show that subtle involvement of the
myocardium is common in DMDch, and early changes in
myocardial physical properties may easily occur indepen-
dently from ECG or two-dimensional echocardiographic
anomalies. Interindividual differences are also common
among DMDch.
Because the identification of molecular markers associ-
ated with the progression of the disease in skeletal muscle
promises to open the way to early genetic therapeutic
treatment in DMD (32), the UTC technique may be a
reliable tool for assessing myocardial changes as well as the
effects of drugs (33) in longitudinal studies.
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